AD symptomatology is initially associated with impaired memory [3] and is defined by the presence of two neuropathological features: amyloid-beta (Aβ) plaques and tau neurofibrillary tangles (NFT) [4]. The gene discussed is MAPT; the disease is Alzheimer disease.